Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly G Knupp

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Epilepsy & Behavior : E&B|February 9, 2025
Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistanceJacob Pellinen, Stefan Sillau, Chris Morrison, et al.
Epilepsy & Behavior : E&B|April 6, 2025
Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: Caregiver and clinician perspectivesCarolyn Condon, Kimberly A Parkerson, Ann Dandurand, et al.
Epilepsy Research|October 8, 2021
Dravet syndrome: A quick transition guide for the adult neurologistDanielle M Andrade, Anne T Berg, Veronica Hood, et al.
Epilepsy Research|April 30, 2023
A comprehensive narrative review of epilepsy with eyelid myocloniaKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|November 14, 2025
Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-UpJoseph Sullivan, Elaine C Wirrell, Kelly G Knupp, et al.
Epilepsia|June 17, 2023
Clinical presentation and evaluation of epilepsy with eyelid myoclonia: Results of an international expert consensus panelKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsia|June 16, 2023
Management of epilepsy with eyelid myoclonia: Results of an international expert consensus panelKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
The New England Journal of Medicine|March 4, 2026
Zorevunersen in Children and Adolescents with Dravet SyndromeLinda Laux, Joseph Sullivan, M Scott Perry, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Epilepsy & Behavior : E&B|February 9, 2025
Cognitive function at the time of focal epilepsy diagnosis is not associated with treatment resistanceJacob Pellinen, Stefan Sillau, Chris Morrison, et al.
Epilepsy & Behavior : E&B|April 6, 2025
Qualitative evaluation of meaningful change in Dravet syndrome as measured by the Vineland-3: Caregiver and clinician perspectivesCarolyn Condon, Kimberly A Parkerson, Ann Dandurand, et al.
Epilepsy Research|October 8, 2021
Dravet syndrome: A quick transition guide for the adult neurologistDanielle M Andrade, Anne T Berg, Veronica Hood, et al.
Epilepsy Research|April 30, 2023
A comprehensive narrative review of epilepsy with eyelid myocloniaKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsy & Behavior : E&B|December 4, 2022
Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopmentKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
Neurology|November 14, 2025
Natural History of Children and Adolescents With Dravet Syndrome: A 24-Month Follow-UpJoseph Sullivan, Elaine C Wirrell, Kelly G Knupp, et al.
Epilepsia|June 17, 2023
Clinical presentation and evaluation of epilepsy with eyelid myoclonia: Results of an international expert consensus panelKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsia|June 16, 2023
Management of epilepsy with eyelid myoclonia: Results of an international expert consensus panelKelsey M Smith, Elaine C Wirrell, Danielle M Andrade, et al.
Epilepsy & Behavior : E&B|August 5, 2021
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growthAntonio Gil-Nagel, Joseph Sullivan, Berten Ceulemans, et al.
The New England Journal of Medicine|March 4, 2026
Zorevunersen in Children and Adolescents with Dravet SyndromeLinda Laux, Joseph Sullivan, M Scott Perry, et al.
Pageof 8